Cargando…

The Role of HDAC6 in Cancer

Histone deacetylase 6 (HDAC6), a member of the HDAC family whose major substrate is α-tubulin, has become a target for drug development to treat cancer due to its major contribution in oncogenic cell transformation. Overexpression of HDAC6 correlates with tumorigenesis and improved survival; therefo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aldana-Masangkay, Grace I., Sakamoto, Kathleen M.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2975074/ https://www.ncbi.nlm.nih.gov/pubmed/21076528 http://dx.doi.org/10.1155/2011/875824

Ejemplares similares

HDAC6 and Ovarian Cancer
por: Haakenson, Joshua, et al.
Publicado: (2013)

Pathological Role of HDAC8: Cancer and Beyond
por: Kim, Ji Yoon, et al.
Publicado: (2022)

HDAC6 in Diseases of Cognition and of Neurons
por: LoPresti, Patrizia
Publicado: (2020)

Role of HDAC6 and Its Selective Inhibitors in Gastrointestinal Cancer
por: Zhou, Bingyi, et al.
Publicado: (2021)

HDAC6 Inhibition Extinguishes Autophagy in Cancer: Recent Insights
por: Passaro, Eugenia, et al.
Publicado: (2021)

HDAC and HDAC Inhibitor: From Cancer to Cardiovascular Diseases
por: Yoon, Somy, et al.
Publicado: (2016)

HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?
por: Simões-Pires, Claudia, et al.
Publicado: (2013)

Hydroxamic acid derivatives as HDAC1, HDAC6 and HDAC8 inhibitors with antiproliferative activity in cancer cell lines
por: Sixto-López, Yudibeth, et al.
Publicado: (2020)

Opposing roles of HDAC6 in liver regeneration and hepatocarcinogenesis
por: Phorl, Sophors, et al.
Publicado: (2022)

Expression of Histone Deacetylases HDAC1, HDAC2, HDAC3, and HDAC6 in Invasive Ductal Carcinomas of the Breast
por: Seo, Jinwon, et al.
Publicado: (2014)

Inhibition of HDAC6 Activity Protects Against Endothelial Dysfunction and Atherogenesis in vivo: A Role for HDAC6 Neddylation
por: Nomura, Yohei, et al.
Publicado: (2021)

Role of HDACs in normal and malignant hematopoiesis
por: Wang, Pan, et al.
Publicado: (2020)

The Role of HDAC6 in Autophagy and NLRP3 Inflammasome
por: Chang, Panpan, et al.
Publicado: (2021)

Immunoepigenetics Combination Therapies: An Overview of the Role of HDACs in Cancer Immunotherapy
por: Banik, Debarati, et al.
Publicado: (2019)

The Therapeutic Strategy of HDAC6 Inhibitors in Lymphoproliferative Disease
por: Cosenza, Maria, et al.
Publicado: (2018)

Targeting HDAC6 to Overcome Autophagy-Promoted Anti-Cancer Drug Resistance
por: Jo, Hyein, et al.
Publicado: (2022)

Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors
por: Thomas, Elizabeth A.
Publicado: (2014)

Overexpressed HDAC8 in cervical cancer cells shows functional redundancy of tubulin deacetylation with HDAC6
por: Vanaja, G. R., et al.
Publicado: (2018)

HDAC6—An Emerging Target Against Chronic Myeloid Leukemia?
por: Losson, Hélène, et al.
Publicado: (2020)

HDAC6 regulates IL-17 expression in T lymphocytes: implications for HDAC6-targeted therapies
por: Yan, Bing, et al.
Publicado: (2017)

ARID1A-mutated ovarian cancers depend on HDAC6 activity
por: Bitler, Benjamin G., et al.
Publicado: (2017)

The Role of HDACs in the Response of Cancer Cells to Cellular Stress and the Potential for Therapeutic Intervention
por: Alseksek, Rahma K., et al.
Publicado: (2022)

SUMOylation inhibition enhances dexamethasone sensitivity in multiple myeloma
por: Du, Li, et al.
Publicado: (2022)

Both HDAC5 and HDAC6 are required for the proliferation and metastasis of melanoma cells
por: Liu, Jiaqi, et al.
Publicado: (2016)

HDAC1 and HDAC6 are essential for driving growth in IDH1 mutant glioma
por: Garrett, Matthew C., et al.
Publicado: (2023)

Metabolism, HDACs, and HDAC Inhibitors: A Systems Biology Perspective
por: King, Jacob, et al.
Publicado: (2021)

Inhibition of HDAC6 activity in kidney diseases: a new perspective
por: Ke, Ben, et al.
Publicado: (2018)

Novel Single Inhibitor of HDAC6/8 and Dual Inhibitor of PI3K/HDAC6 as Potential Alternative Treatments for Prostate Cancer
por: Guerra, Fabiana Sélos, et al.
Publicado: (2021)

The Role of HDAC6 in TDP-43-Induced Neurotoxicity and UPS Impairment
por: Lee, Shinrye, et al.
Publicado: (2020)

The Role of HDACs Inhibitors in Childhood and Adolescence Acute Leukemias
por: Masetti, Riccardo, et al.
Publicado: (2011)

The Role of HDACs as Leukemia Therapy Targets using HDI
por: Ahmadzadeh, Ahmad, et al.
Publicado: (2015)

Inhibition of HDAC3- and HDAC6-Promoted Survivin Expression Plays an Important Role in SAHA-Induced Autophagy and Viability Reduction in Breast Cancer Cells
por: Lee, Jane Ying-Chieh, et al.
Publicado: (2016)

Divergent roles of HDAC1 and HDAC2 in the regulation of epidermal development and tumorigenesis
por: Winter, Mircea, et al.
Publicado: (2013)

Role of HDAC3-miRNA-CAGE Network in Anti-Cancer Drug-Resistance
por: Kwon, Yoojung, et al.
Publicado: (2018)

Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer
por: Yang, Chun, et al.
Publicado: (2021)

The Role of Dietary Histone Deacetylases (HDACs) Inhibitors in Health and Disease
por: Bassett, Shalome A., et al.
Publicado: (2014)

The Emerging Role of HDACs: Pathology and Therapeutic Targets in Diabetes Mellitus
por: Dewanjee, Saikat, et al.
Publicado: (2021)

Novel dual LSD1/HDAC6 inhibitor for the treatment of cancer
por: Gajendran, Chandru, et al.
Publicado: (2023)

HDAC6 Regulates LPS-Tolerance in Astrocytes
por: Beurel, Eléonore
Publicado: (2011)

HDAC6 modulates myofibril stiffness and diastolic function of the heart
por: Lin, Ying-Hsi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kmfigu5m4lrpgolkpjg4edi39q